Montevideo, Aug 6 (EFE) .- Uruguay refines the details for the opening of its borders to non-resident foreigners in that country after more than a year of closure by the covid-19 and this Monday there will be announcements in this regard by the Executive , confirmed to Efe this Friday official sources.
According to the latest information, foreigners with properties in the South American country would be the first to enter the framework of a series of measures that the Uruguayan government is preparing to reactivate the tourism sector, which has been one of the most affected during the pandemic.
The country’s borders continue to be closed to non-residents, with exceptions for diplomatic, personal or economic-labor reasons, with the express authorization of the Executive.
Uruguay’s Minister of Tourism, Germán Cardoso, said at a press conference last Monday that an opening is planned in two stages, the first being that of foreigners with properties.
In the second stage, and if sanitary conditions allow it, the entry of foreigners in general will be enabled, although in both cases all visitors will be required to be vaccinated against covid-19.
Uruguay remains in the yellow zone of the Harvard index, which accumulates the weekly average of new cases of covid-19 per 100,000 inhabitants, with a record of 4.34 and, although all the departments have active cases, three of the 19 —Rivera (north), Durazno (center) and Lavalleja (southeast) – are already in green, according to the daily report of the National Emergency System (Sinae).
With regard to vaccination, and according to the web monitor developed by the Ministry of Public Health (MSP), until 13.25 hours (16.25 GMT) this Friday, 315,444 people have been inoculated with only the first dose, while 2,277. 909 (64.29% of the population) have already completed the immunization schedule of the Chinese pharmaceutical companies Sinovac, the Anglo-Swedish AstraZeneca and the American Pfizer.
Uruguay opened the agenda this week for those who – after being immunized with Coronavac or AstraZeneca – choose to receive a third dose, in this case from Pfizer, as approved last week by the health authorities.